Sab biotherapeutics appoints michael g. king jr. as chief financial officer

Finance leader joins sab with more than 25 years of experience as a leading biotech equity research analyst finance leader joins sab with more than 25 years of experience as a leading biotech equity research analyst
SABS Ratings Summary
SABS Quant Ranking